Isolation from Streptomyces of a Novel Naphthoquinone Compound, Naphthablin, That Inhibits Abl Oncogene Functions

13Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

In the course of our screening for inhibitors of abl oncogene function, a culture filtrate of Streptomyces aculeolatus. induced normal flat morphology in v-abl-expressing NIH3T3 cells. The active substance was isolated through ethyl acetate extraction, silica gel column chromatography, and reverse-phase HPLC. Mass and NMR spectroscopy including HMBC revealed that it had a novel naphthoquinone structure with a monoterpene, and we named it “naphthablin”. Naphthablin inhibited Abl-induced morphological transformation in v-ablts-NIH3T3 cells at around 30μg/ml, and specifically inhibited RNA synthesis. © 1995, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Naganawa, H., Kondo, S., Ikeda, Y., Klnoshita, N., Hamada, M., Sawa, T., & Takeuchi, T. (1995). Isolation from Streptomyces of a Novel Naphthoquinone Compound, Naphthablin, That Inhibits Abl Oncogene Functions. The Journal of Antibiotics, 48(7), 604–607. https://doi.org/10.7164/antibiotics.48.604

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free